Rifapentine: A Viewpoint by C.M. Tam

ISSN： 0012-6667

Source： Drugs, Vol.56, Iss.4, 1998-10, pp. : 617-617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rifapentine

By Jarvis B. Lamb H.M.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 607-616

Adis International

Access to resources Recommend Favorite

Zanamivir: A Viewpoint by Douglas M. Fleming

By Fleming D.M.

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 726-727

Adis International

Access to resources Recommend Favorite

Clopidogrel: A Viewpoint by Robert M. Califf

By Califf R.M.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 476-476

Adis International

Access to resources Recommend Favorite

Oseltamivir: A Viewpoint by D.M. Fleming

By Fleming D.M.

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 861-862

Adis International

Access to resources Recommend Favorite

Palonosetron: A Viewpoint by Roberto M. Labianca

By Labianca R.M.

Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. : 1133-1134

Adis International

Access to resources Recommend Favorite